Healthcare

Polarean Imaging plc (LSE:POLX), a medical imaging technology company focused on functional MRI of the lungs, has announced the installation of its first Xenon MRI research system in Taiwan. The system will be delivered to the National Taiwan University Hospital (NTUH), recognized as the …

OptiBiotix Health plc (LSE:OPTI), a life sciences business developing products to reduce hunger, support gut microbiome health, and provide sugar alternatives, has received its first order from a well-known European weight management company. The low six-figure order includes private label SlimBiome® finished products—gummies, bars, …

Abingdon Health plc (LSE:ABDX) has secured a new contract with an expected value of approximately USD 2m. The agreement, structured as a Master Service Agreement (MSA) with a US-based company, covers the development, scale-up, and technical transfer of a semi-quantitative, multiplex lateral flow test …

Hikma Pharmaceuticals PLC (LSE:HIK), the multinational pharmaceutical group, continues to attract favorable analyst sentiment, with key brokerages maintaining ‘Buy’ recommendations, might be following the company’s interim financial performance for the six months ended 30 June 2025.

Renalytix plc (LSE:RENX), a precision medicine diagnostics company, announced its audited results for the fiscal year ended 30 June 2025. The company reported totalrevenueof USD 3.0 million, up 30% from FY2024 (USD 2.3 million), supported by testing growth and increased pharmaceutical services revenue.

Optima Health plc (LSE:OPT), a UK-based provider of technology-enabled corporate health and wellbeing services, announced its unaudited trading update for the half year ended 30 September 2025 (“H1 26”).

Rothschild & Co Redburn (LSE:RKT) has issued a‘Buy’rating on Reckitt Benckiser Group plc (LSE:RKT), setting a target price of GBP 6,700, reflecting an upside potential of 13.75% from current levels. The rating follows the company’s announcement of its Q3 2025 performance, highlighting sustained growth …